Home›Research›Compare›GLP-1 (7-37) vs Retatrutide
Peptide Comparison
GLP-1 (7-37) vs Retatrutide
Both are Fat Loss peptides.
Retatrutide
LY3437943
Half-life: ~6 days
73 providers listed
Quick Verdict
GLP-1 (7-37)
Risk
Half-life
—
Retatrutide
Risk
Half-life
~6 days
Side-by-Side Comparison
About GLP-1 (7-37)
Binds GLP-1 receptors in the pancreas, gut, and brain. Stimulates glucose-dependent insulin secretion and suppresses glucagon. Central GLP-1 receptor activation reduces food intake via hypothalamic pathways.
The active endogenous form of glucagon-like peptide-1, an incretin hormone released from intestinal L-cells after eating. The mechanistic basis for the GLP-1 receptor agonist drug class (semaglutide, liraglutide). Studied for glucose regulation and appetite suppression.
Research Areas
About Retatrutide
Triple GIP/GLP-1/glucagon receptor agonist; targets three pathways for synergistic fat reduction
A triple agonist peptide in clinical development showing exceptional weight loss results (up to 24% body weight). Targets GIP, GLP-1, and glucagon receptors simultaneously.
Research Areas
Find Providers
Where to source these peptides
Providers offering
GLP-1 (7-37)
29 listed
Browse directory →
Providers offering
Retatrutide
73 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More fat loss Comparisons
Browse all peptides →Educational research tools — not medical advice.